Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement in central nervous system inflammation.

Scott R Barnum1

  • 1Department of Microbiology, University of Alabama at Birmingham, 35294, USA. sbarnum@uab.edu

Immunologic Research
|October 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: The impact of COVID-19 on immune system-related complications in surgical patients.

Frontiers in surgery·2023
Same author

Periodontal Infection Aggravates C1q-Mediated Microglial Activation and Synapse Pruning in Alzheimer's Mice.

Frontiers in immunology·2022
Same author

Soluble Membrane Attack Complex: Biochemistry and Immunobiology.

Frontiers in immunology·2020
Same author

RNASeq analysis reveals upregulation of complement C3 in the offspring gut following prenatal stress in mice.

Immunobiology·2020
Same author

Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option.

Frontiers in immunology·2020
Same author

Epidemiology of lumbar punctures in hospitalized patients in the United States.

PloS one·2018
Same journal

Emapalumab plus conventional therapy with or without ruxolitinib for pediatric hemophagocytic lymphohistiocytosis: a single center retrospective study.

Immunologic research·2026
Same journal

Immunological spectrum in patients with thymoma: beyond good syndrome.

Immunologic research·2026
Same journal

Microbiome immune crosstalk in Sjögren's syndrome: mechanistic insights and translational perspectives.

Immunologic research·2026
Same journal

Immune checkpoint inhibitor-induced myasthenia gravis and myocarditis: a fatal immune-related adverse event.

Immunologic research·2026
Same journal

TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence.

Immunologic research·2026
Same journal

Decoding PANoptosis: Crosstalk of cell death pathways in immunity and inflammation.

Immunologic research·2026
See all related articles

The complement system is active in the brain, with receptors on neurons potentially modulating function. Inhibiting this system shows promise for treating multiple sclerosis and similar neurological diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Complement system biology

Background:

  • The complement system, a key part of innate immunity, is present in the central nervous system (CNS).
  • Glial cells and neurons in the CNS express all necessary complement activation and regulatory proteins, as well as C3a and C5a receptors.

Purpose of the Study:

  • To investigate the role and potential therapeutic targeting of the complement system in the CNS.
  • To explore the expression and function of C3a/C5a receptors in neuronal cells.

Main Methods:

  • Review of existing literature on complement system components in the CNS.
  • Analysis of experimental data from models of neurological diseases, specifically experimental allergic encephalomyelitis (EAE).

Main Results:

Related Experiment Videos

  • Complement activation and regulatory proteins, along with C3a/C5a receptors, are produced or expressed by CNS cells like glial cells and neurons.
  • Inhibition of complement activation demonstrated a protective effect in experimental allergic encephalomyelitis (EAE), a model for multiple sclerosis.
  • C3a/C5a receptors are broadly expressed on neurons, suggesting a role in modulating neuronal function.

Conclusions:

  • The complement system is integral to CNS function and disease processes.
  • Targeting complement activation pathways offers a potential therapeutic strategy for neurological disorders such as multiple sclerosis.
  • Neuronal expression of C3a/C5a receptors indicates a direct role in neural function, opening avenues for novel therapeutic interventions.